In order to move a step beyond systematic responses with the aim of elaborating upon the potential role of mucosal immunity of the GI compartment on disease development and progression, we assessed cytokine levels (TNFα, IL-1β, and IL-6) in the duodenal aspirate of patients with NAFLD as well as in healthy controls. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.